New Issue: UBS prices $173,862 10.77% trigger yield optimization notes on Biotech ETF

New York, June 8 – UBS AG, London Branch priced $173,862.16 of 10.77% trigger yield optimization notes due July 19 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The face amount of each note is $81.32, which is equal to the initial share price of the ETF.

Interest is payable monthly.

The payout at maturity will be par unless the final share price is less than 70% of the initial share price, in which case investors will receive one SPDR share per note.

UBS Financial Services Inc. and UBS Investment Bank are the underwriters.

Issuer:	UBS AG, London Branch
Issue:	Trigger yield optimization notes
Underlying ETF:	SPDR S&P Biotech ETF
Amount:	$173,862.16
Maturity:	July 19
Coupon:	10.77%, payable monthly
Price:	Par of $81.32
Payout at maturity:	If final share price is less than trigger price, one SPDR share; otherwise, par
Initial share price:	$81.32
Trigger price:	$56.92, 70% of initial price
Pricing date:	July 14, 2022
Settlement date:	July 18, 2022
Underwriters:	UBS Financial Services Inc. and UBS Investment Bank
Fees:	2%
Cusip:	90303R170

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.